GM 90581
Alternative Names: GM-90581Latest Information Update: 10 Jun 2022
At a glance
- Originator JD BIOSCIENCE
- Class Antineoplastics; Hepatoprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Non-alcoholic steatohepatitis; Triple negative breast cancer
Most Recent Events
- 10 Jun 2022 GM 90581 is available for licensing as of 10 Jun 2022. http://jdbiosci.com/sub_collabo.php
- 10 Jun 2022 Early research in Non-alcoholic steatohepatitis in South Korea (unspecified route) before June 2022 (JD BIOSCIENCE pipeline, June 2022)
- 10 Jun 2022 Early research in Triple negative Breast cancer in South Korea (unspecified route) before June 2022 (JD BIOSCIENCE pipeline, June 2022)